April 1, 2025 - 01:16
The Fifth Circuit’s recent ruling in the case of Grigsby highlights the critical importance for taxpayers to explicitly define their business components when preparing and documenting claims for the Section 41 research credit. This decision underscores that a precise and detailed identification of business components is not merely a formality but a fundamental requirement in the process of claiming research tax credits.
Taxpayers are encouraged to meticulously outline the various components of their business activities that qualify for this credit, as the court’s ruling indicates that ambiguity or lack of detail can jeopardize their claims. The ruling serves as a reminder that thorough documentation and a clear understanding of what constitutes a business component are essential in successfully navigating the complexities of tax credits related to research and development.
As businesses strive to leverage available tax incentives, this decision reinforces the need for diligence and clarity in their documentation processes to ensure compliance and maximize potential benefits.
June 15, 2025 - 11:02
Pacers Come to Aid of Local Bakery Targeted by NBA Finals ScamINDIANAPOLIS — For any small business, receiving a call from the Indiana Pacers is often a cause for excitement. This was certainly the case for the team at Sweet Escape Cake Company when they...
June 14, 2025 - 18:23
Walla Walla University Students Shine at Virtual ConferenceWalla Walla University students Maleah Moses and Alden Wilfley recently showcased their talents by presenting at the prestigious 2025 Adventist Association of Movement Professionals Conference. The...
June 14, 2025 - 02:04
Why Your Business Should Embrace MCP: The Model Context ProtocolIn today’s data-driven world, businesses are constantly seeking innovative ways to leverage their data for strategic advantage. One emerging tool that stands out is MCP, or Model Context Protocol...
June 13, 2025 - 11:17
Thermo Fisher Plans to Divest Diagnostics Business for $4 BillionIn a strategic move to streamline operations, Thermo Fisher Scientific is reportedly looking to sell parts of its diagnostics business, with an estimated value of around $4 billion. This decision...